What is Ibrutix (Ibrutinib)?
Ibrutinib is a BTK inhibitor used in certain blood cancers. It works by blocking a protein (BTK) that cancer cells use to grow and survive.
🧬 Common uses of Ibrutix 140 mg
Doctors prescribe it mainly for:
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Mantle Cell Lymphoma (MCL)
- Waldenström’s macroglobulinemia
⚙️ How Does Ibrutix 140 mg Work?
Think of cancer cells like “signal-dependent machines.” Ibrutinib shuts off a key signal pathway (BTK), so the cancer cells:
- stop multiplying
- become weaker
- eventually die off
⚠️ Common Side Effects of Ibrutix 140 mg
Some people may experience:
- Diarrhea
- Fatigue
- Easy bruising or bleeding
- Muscle/joint pain
- Low blood counts
- Increased infection risk
🚨 Important precautions
- Not for self-medication — must be prescribed by an oncologist
- Can increase bleeding risk (important if you take aspirin or blood thinners)
- Needs regular blood tests during treatment
- Infection monitoring is very important

Reviews
There are no reviews yet.